EMA Authorised: Yaxwer (denosumab) — Gedeon Richter Plc.

View source ↗

Summary

EMA authorised Yaxwer (denosumab) by Gedeon Richter Plc. for neoplasms involving bone tissue, including giant cell tumor of bone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone
• Neoplasms of Bone Tissue

Drugs mentioned

• Yaxwer (denosumab)

Snippet

Status: Authorised. Therapeutic area: Neoplasms, Bone Tissue;Giant Cell Tumor of Bone. MAH: Gedeon Richter Plc.. Decision date: 13/08/2026